Figure 2.
Inflammatory biomarker expression. (A) Proportion of inflammatory biomarkers increasing or decreasing from baseline in placebo and LSALT peptide-treated groups (fold induction of all biomarkers and all time points, n=635 placebo, n=686 LSALT peptide; Fisher’s exact test). (B) Mean fold induction of C-X-C motif chemokine ligand 10 (CXCL10) in 2-hour biomarker samples at end of treatment (EOT) (mean±SD; n=25 placebo, n=25 LSALT peptide; Mann-Whitney test).